Founder mutations in xeroderma pigmentosum
- PMID: 20463673
- PMCID: PMC3486739
- DOI: 10.1038/jid.2010.76
Founder mutations in xeroderma pigmentosum
Abstract
In this issue, Soufir et al. report a founder mutation in the XPC DNA repair gene in 74% of families with xeroderma pigmentosum (XP) in the Maghreb region (Algeria, Morocco, and Tunisia) of northern Africa. These patients have a high frequency of skin cancer. The presence of this founder mutation provides an opportunity for genetic counseling and early diagnosis of XP.
Conflict of interest statement
Conflict of Interest: The authors state no conflict of interest.
Figures
Comment on
-
A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.J Invest Dermatol. 2010 Jun;130(6):1537-42. doi: 10.1038/jid.2009.409. Epub 2010 Jan 7. J Invest Dermatol. 2010. PMID: 20054342
References
-
- Ben RM, Messaoud O, Talmoudi F, et al. High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis. J Hum Genet. 2009;54:426–9. - PubMed
-
- Gozukara EM, Khan SG, Metin A, et al. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J Invest Dermatol. 2001;117:197–204. - PubMed
-
- Hirai Y, Kodama Y, Moriwaki S, et al. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutat Res. 2006;601:171–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
